RESEARCH TRIANGLE PARK, N.C. – March 25, 2015 – Quintiles, the world’s largest biopharmaceutical services company, has been named to Forbes magazine’s first-ever “America’s Best Employers” list as rated by more than 20,000 independent survey responses.

Quintiles is ranked as the 30th best employer in the United States and comes in third in the “Drugs and Biotechnology” category. In all, 500 companies are included in the 2015 Forbes list.

“Being named one of the top employers in the U.S. is a great honor for Quintiles and says a lot about our values, our people and company mission,” said Chief Human Resources Officer Garrett Walker. “Our organization is committed to building and sustaining a work environment that enables our talent to be high performing, successful in achieving their professional development goals and provides multiple career paths and opportunities.”

Forbes’ Methodology

The Forbes ranking of top employers is drawn from an online survey of 20,000 American workers at large U.S. companies, nonprofit institutions such as hospitals, government agencies, and U.S. divisions of multinationals, asking them to provide their opinions on their employers and others in their industry with which they were familiar.

Surveyed employees were asked, “On a scale of 1-10, how likely would you be to recommend your employer to someone else? How about other employers in your industry?”

Forbes’ statistics partner, Statista, evaluated the data and identified 3,500 employers for whom there was a statistically relevant result. From that pool, the top 500 companies made the Forbes list. Those 500 were split up into 27 industry categories covering all aspects of the American economy.

About Quintiles

Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.

Contact:
Phil Bridges, Media Relations (phil.bridges@quintiles.com)
+ 1.919.998.1653 (office) +1.919.457.6347 (mobile)

Karl Deonanan, Investor Relations (InvestorRelations@quintiles.com)
+1.919.998.2789